Trial Profile
Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI) in the Treatment of Hepatic Colorectal Metastases
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 12 Feb 2017 Status changed from recruiting to completed.
- 04 Feb 2015 New trial record